Loading...
Docoh

PDS Biotechnology (PDSB)

Employees
Data from SEC filings
Employee count
ESG framework mentions
In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions
Shareholder alignment
Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM


PDS Biotechnology Corporation (the “Company”) held its 2022 annual meeting of stockholders on June 15, 2022 (the “Annual Meeting”). At the Annual Meeting, the following proposals were submitted to the stockholders of the Company:


Proposal 1:A proposal to elect Stephen Glover, Gregory Freitag, and Sir Richard Sykes to serve as Class A directors until the Company’s 2025 annual meeting of stockholders or until their successors are duly elected and qualified.
Proposal 2:A proposal to ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022.
Proposal 3:A proposal to approve, by non-binding advisory vote, the compensation of the Company’s named executive officers.


For more information about the foregoing proposals, see the Company’s definitive proxy statement on Schedule 14A filed with the United States Securities and Exchange Commission on April 29, 2022. Of the 28,450,894 shares of the Company’s common stock entitled to vote at the Annual Meeting, 17,619,466 shares, or approximately 61.92%, were represented at the Annual Meeting in person or by proxy, constituting a quorum. The number of votes cast for, against or withheld, as well as abstentions and broker non-votes, if applicable, in respect of each such proposal is set forth below.


Proposal 1:Election of Class A Directors.



The Company’s stockholders elected the following directors to serve as Class A directors until the 2025 annual meeting of stockholders of the Company or until their successors are duly elected and qualified. The votes regarding the election of the directors were as follows:


DirectorVotes ForVotes WithheldBroker Non-Votes
Stephen Glover5,702,0172,049,0139,868,436
Gregory Freitag5,640,8162,110,2149,868,436
Sir Richard Sykes6,275,6151,475,4159,868,436


Proposal 2:Ratification of Appointment KPMG LLP



The Company’s stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022. The votes regarding this proposal were as follows:


Votes ForVotes AgainstVotes AbstainingBroker Non-Votes
17,533,41185,9121430


Proposal 3:Approval, by non-binding advisory vote, of the compensation of the Company’s named executive officers.



The Company’s stockholders voted to approve, by non-binding advisory vote, the compensation of the Company’s named executive officers. The votes regarding this proposal were as follows:


Votes ForVotes AgainstVotes AbstainingBroker Non-Votes
6,423,1991,245,60182,2309,868,436